Subject characteristics before and after 26-wks treatment with VAL or PLB.

Abstract

<p>BMI, body mass index; HbA1C, glycated haemoglobin; NEFA, non-esterified fatty acid; SBP, systolic blood pressure; DBP, diastolic blood pressure; TAG, triacylglycerol; WHR, waist-to-hip ratio; <i>N.S.</i>, not significant. ^*VAL <i>vs.</i> PLB treatment assessed by repeated-measures ANOVA. ^#<i>P</i><0.05 <i>vs</i>. PLB. Values are means±SEM.</p